What does it take to turn a powerful psychedelic experience into responsible clinical care?

In this TEDMED Conversation, Heidi Allen joins Jay Walker to examine the rapidly changing future of psychedelic-assisted therapy: what patients may need, what clinicians must be trained to provide, and what could get lost as the field moves toward approval, reimbursement, and scale.

Heidi looks beyond the excitement around new treatments to ask harder questions about safety, access, ethics, and implementation. How should therapists be trained for this work? What role should preparation and follow-up play? And if regulators and companies simplify care models to fit existing approval pathways, will patients receive the kind of support these treatments actually require?

The conversation explores a field at a turning point, where scientific promise, commercial pressure, clinical responsibility, and patient need are all colliding.

For full show notes and more from TEDMED, visit TEDMED.com.

Podden och tillhörande omslagsbild på den här sidan tillhör TEDMED. Innehållet i podden är skapat av TEDMED och inte av, eller tillsammans med, Poddtoppen.